Surgery Websites
Transplant Surgery »  Meet the Team »  Hepatology »  Norah A. Terrault, M.D., M.P.H.
Norah A. Terrault, M.D., M.P.H.

Norah A. Terrault, M.D., M.P.H.

Professor of Clinical Medicine & Surgery
Departments of Medicine & Surgery
Director of Viral Hepatitis Research in Liver Transplantation

Contact Information

Academic Office
Division of Gastroenterology
513 Parnassus Avenue, Room S-357
San Francisco, CA 94143-0358
Phone: (415) 476-2227
415-476-0659
norah.terrault@ucsf.edu
 
Open Popup
  • 1985 B.MSc., University of Alberta
  • 1987 M.D., University of Alberta
  • 1997 M.P.H. University of California, Berkeley
  • 1987-88 Internship, University of Toronto
  • 1988-91 Internal Medicine, University of Toronto
  • 1991-93 Gastroenterology, University of Toronto
  • 1994-95 Clinical Hepatology, Division of Gastroenterology, University of Toronto

  • 1995-97 Research Hepatology, Division of Gastroenterology, UCSF Medical Center

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Gastroenterology
  • UCSF Liver Center
  • Hepatitis B virus (HBV)
  • Hepatitis C virus (HCV)
  • Liver Injury and Repair

Dr. Norah Terrault is a hepatologist or liver specialist who is recognized internationally for the treatment of viral hepatitis and liver transplantation. Her research includes the study of viral hepatitis and its progression and treatment, especially in liver transplant patients. Her research includes several clinical trials related to preventing and treating chronic hepatitis C and B. Her studies in this area have been presented to the American Association for the Study of Liver Diseases, the leading organization for research in liver disease.

Terrault completed medical training at the University of Alberta and specialty medical training in Internal Medicine and Gastroenterology at the University of Toronto, both in Canada. Her post-doctoral fellowship in hepatology and viral hepatitis was completed at the University of California, San Francisco while earning a concurrent master's degree in public health from the University of California at Berkeley. She joined the medical staff at UCSF Medical Center in 1997.

My research focuses on the natural history and treatment of hepatitis C virus (HCV) and hepatitis B virus (HBV), particularly in special populations, including those undergoing liver transplantation. Work in progress addresses the natural history of post-transplant disease and specific therapies to prevent infection or modify HCV and HBV disease progression and loss of grafts from recurrent disease.

Our virological analyses are focused on characterization of viral mutations that occur in liver transplant recipients receiving antiviral therapies and assessment of the effect of these variant viruses on the natural history and severity of disease post-transplantation. Knowledge of these factors may allow improved organ allocation by identifying subsets of patients with HCV recurrence in liver grafts who would be favorable or unfavorable candidates for retransplantation. 

MOST RECENT PUBLICATIONS FROM A TOTAL OF 287
Publications provided by UCSF Profiles, powered by CTSI.
  1. Roth D, Bloom RD, Molnar MZ, Reese PP, Sawinski D, Sise ME, Terrault NA. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C. Am J Kidney Dis. 2020 May; 75(5):665-683. View in PubMed
  2. Verna EC, Morelli G, Terrault NA, Lok AS, Lim JK, Di Bisceglie AM, Zeuzem S, Landis CS, Kwo P, Hassan M, Manns MP, Vainorius M, Akushevich L, Nelson DR, Fried M MW, Reddy KR. DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort. J Hepatol. 2020 Mar 31. View in PubMed
  3. Terrault N. Transplanting Kidneys from Donors with Chronic Hepatitis B: Bringing Transmission Risk Closer to Zero. Clin Infect Dis. 2020 Feb 25. View in PubMed
  4. Ayyala-Somayajula D, Han H, Terrault NA. Selective use of liver transplantation for severe alcohol-associated hepatitis. Expert Rev Gastroenterol Hepatol. 2020 Mar; 14(3):175-184. View in PubMed
  5. Terrault NA, Feld JJ. Safety First: Favoring Prophylactic/Preemptive over Delayed Treatment in D+/R- Transplants. Hepatology. 2020 Feb 14. View in PubMed
  6. View All Publications

 

Site Directory
    X